Jepsen IE

ORCID: 0000-0002-4632-4292 · 3 papers in corpus
other 2026
Efficacy of follitropin delta in potential low responders: a pooled analysis of individual patient data from five randomized controlled trials
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1880515

OBJECTIVES: This study evaluated the efficacy of individualized follitropin delta dosing in patients with potential low response, defined by anti-Müllerian hormone (AMH) level <9 pmol/L, undergoing ovarian stimulation for assisted reproduct…

meta-analysis 2025
One-year cumulative live birth rate associated with the number of oocytes in ovarian stimulation with follitropin delta: a pooled analysis of four randomized controlled trials
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf111

STUDY QUESTION: What number of oocytes retrieved is associated with the highest cumulative live birth rates (CLBRs) in the fresh and subsequent frozen cycles following ovarian stimulation with follitropin delta? SUMMARY ANSWER: The CLBR in…

rct 2025
Ovarian stimulation with follitropin delta for in vitro fertilization: a multicentre, randomized, assessor-blind comparison with follitropin alfa using conventional dosing regimens (ADAPT-1 trial)
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf119

STUDY QUESTION: How do ovarian responses using conventional dosing for follitropin delta 15 µg/day compare with follitropin alfa 225 IU/day in women undergoing ovarian stimulation? SUMMARY ANSWER: The ADAPT-1 trial demonstrates similar ova…